| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0009-2797(02)00006-6 |
| P698 | PubMed publication ID | 11879818 |
| P50 | author | Masanori Katakura | Q42805224 |
| P2093 | author name string | Yasunori Sato | |
| Naomi Kudo | |||
| Yoichi Kawashima | |||
| P2860 | cites work | Sex Difference in the Transport of p-Aminohippurate by the Rat Kidney1 | Q72763395 |
| Induction by perfluorinated fatty acids with different carbon chain length of peroxisomal beta-oxidation in the liver of rats | Q73439900 | ||
| Fish oil-feeding prevents perfluorooctanoic acid-induced fatty liver in mice | Q73614708 | ||
| Identification of androgen-regulated genes in mouse kidney by representational difference analysis and random arbitrarily primed polymerase chain reaction | Q74117421 | ||
| An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid | Q74802865 | ||
| Alterations by perfluorooctanoic acid of glycerolipid metabolism in rat liver | Q77398146 | ||
| Sex-dependent pharmacokinetics and in vitro reductive metabolism of acetohexamide in Wistar-Imamichi rats | Q77752436 | ||
| Determination of perfluorinated carboxylic acids in biological samples by high-performance liquid chromatography | Q77804286 | ||
| Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1 | Q22009932 | ||
| Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins, and cholesterol: A study of occupationally exposed men | Q24169422 | ||
| Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain | Q28374528 | ||
| Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain | Q28569041 | ||
| Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney | Q28577503 | ||
| Expression cloning and characterization of a novel multispecific organic anion transporter | Q28581792 | ||
| Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers | Q33924739 | ||
| Cellular and molecular aspects of drug transport in the kidney | Q34023104 | ||
| Identification and functional characterization of the promoter region of the human organic anion transporting polypeptide gene | Q34442016 | ||
| Expression cloning of a rat liver Na(+)-independent organic anion transporter | Q34907393 | ||
| Effects of perfluoro-n-decanoic acid on the respiratory activity of isolated rat liver mitochondria | Q41225651 | ||
| Biochemical and morphological studies of ammonium perfluorooctanoate-induced hepatomegaly and peroxisome proliferation | Q42218922 | ||
| Sex- and species-related nephropathy of 6-(1-aminocyclohexanecarboxamido)penicillanic acid (cyclacillin) and its relationship to the metabolic disposition of the drug | Q42231659 | ||
| Evidence for the active renal secretion of S-pentachlorophenyl-N-acetyl-L-cysteine by female rats | Q42254460 | ||
| Effect of the peroxisome proliferator, ammonium perfluorooctanoate (C8), on hepatic aromatase activity in adult male Crl:CD BR (CD) rats | Q42553994 | ||
| Characterization of hepatic responses of rat to administration of perfluorooctanoic and perfluorodecanoic acids at low levels | Q42679333 | ||
| Comparison of the elimination between perfluorinated fatty acids with different carbon chain length in rats | Q43580786 | ||
| Mechanism of the serum thyroid hormone lowering effect of perfluoro-n-decanoic acid (PFDA) in rats | Q43790897 | ||
| Oatp2 mediates bidirectional organic solute transport: a role for intracellular glutathione | Q48886402 | ||
| Toxicokinetics of inhaled 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in F344 rats and B6C3F1 mice. | Q50849492 | ||
| Sex differences in the metabolism of hexachlorobenzene by rats and the development of porphyria in females. | Q52531829 | ||
| A pharmacokinetic analysis program (multi) for microcomputer | Q52732710 | ||
| Renal excretion of perfluorooctanoic acid in male rats: inhibitory effect of testosterone | Q67536067 | ||
| Effects of perfluoro fatty acids on xenobiotic-metabolizing enzymes, enzymes which detoxify reactive forms of oxygen and lipid peroxidation in mouse liver | Q67568982 | ||
| Sex differences in excretion of zenarestat in rat | Q67854370 | ||
| The role of age and sex hormones on the urinary excretion of zenarestat in rats | Q67867133 | ||
| Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats | Q68045036 | ||
| Lack of evidence for perfluorodecanoyl- or perfluorooctanoyl-coenzyme A formation in male and female rats | Q68128859 | ||
| Stimulation by oestradiol of the urinary excretion of perfluorooctanoic acid in the male rat | Q69389296 | ||
| The sex-related difference in perfluorooctanoate excretion in the rat | Q70525268 | ||
| Metabolic Handling of perfluorooctanoic acid in rats | Q71130505 | ||
| Health status of plant workers exposed to fluorochemicals--a preliminary report | Q71286598 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 301-316 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Chemico-biological Interactions | Q14923137 |
| P1476 | title | Sex hormone-regulated renal transport of perfluorooctanoic acid | |
| P478 | volume | 139 |
| Q51804686 | Absorption, distribution, and excretion of ammonium perfluorooctanoate (APFO) after oral administration to various species. |
| Q36326773 | Application of physiologically-based pharmacokinetic modeling to explore the role of kidney transporters in renal reabsorption of perfluorooctanoic acid in the rat. |
| Q39129370 | Binding of perfluorooctanoic acid to rat liver-form and kidney-form alpha2u-globulins |
| Q28478470 | Biological responses to perfluorododecanoic acid exposure in rat kidneys as determined by integrated proteomic and metabonomic studies |
| Q60921076 | Changes in hepato-renal gene expression in microminipigs following a single exposure to a mixture of perfluoroalkyl acids |
| Q44890057 | Characterization of risk for general population exposure to perfluorooctanoate |
| Q28251251 | Chromosomal aneuploidies and DNA fragmentation of human spermatozoa from patients exposed to perfluorinated compounds |
| Q46975539 | Combining perfluoroalkane acid exposure levels for risk assessment |
| Q48552648 | Common carp Cyprinus carpio responses to sub-chronic exposure to perfluorooctanoic acid |
| Q34571004 | Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters |
| Q45722668 | Comparing models for perfluorooctanoic acid pharmacokinetics using Bayesian analysis |
| Q44260358 | Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length |
| Q42915431 | Determining the molecular interactions of perfluorinated carboxylic acids with human sera and isolated human serum albumin using nuclear magnetic resonance spectroscopy. |
| Q36411181 | Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages |
| Q48607334 | Distribution of perfluoroalkyl compounds in rats: Indication for using hair as bioindicator of exposure |
| Q56983506 | Dosimetric Anchoring of Toxicological Studies |
| Q46785218 | Dosimetric anchoring of in vivo and in vitro studies for perfluorooctanoate and perfluorooctanesulfonate |
| Q40501559 | Effect of gonadectomy and hormones on sex differences in ketoprofen enantiomer glucuronidation and renal excretion of formed glucuronides in the rat. |
| Q46895745 | Effects of perfluorooctanoic acid exposure during pregnancy in the mouse |
| Q37521097 | Effects of pharmaceuticals and other active chemicals at biological targets: mechanisms, interactions, and integration into PB-PK/PD models. |
| Q73270085 | Endocrine Regulation of Rat Organic Anion Transporters |
| Q36335726 | Endocrine and metabolic regulation of renal drug transporters |
| Q37198714 | Environmental and biological monitoring of persistent fluorinated compounds in Japan and their toxicities |
| Q89722945 | Evaluating thyroid hormone disruption: investigations of long-term neurodevelopmental effects in rats after perinatal exposure to perfluorohexane sulfonate (PFHxS) |
| Q44550012 | Evaluation and prediction of pharmacokinetics of PFOA and PFOS in the monkey and human using a PBPK model |
| Q36885491 | Gender differences in kidney function. |
| Q46750192 | Gene expression profiles in rat liver treated with perfluorooctanoic acid (PFOA). |
| Q23911989 | Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice |
| Q42629091 | HPLC determination of perfluorinated carboxylic acids with fluorescence detection |
| Q34680365 | Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers |
| Q85844360 | Human serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in Uyghurs from Sinkiang-Uighur Autonomous Region, China: background levels study |
| Q49935950 | Impact of perfluorochemicals on human health and reproduction: a male's perspective |
| Q34503470 | In Vitro Screening for Population Variability in Chemical Toxicity |
| Q91948873 | Interspecies differences in perfluoroalkyl substances (PFAS) toxicokinetics and application to health-based criteria |
| Q37784718 | Isomer Profiling of Perfluorinated Substances as a Tool for Source Tracking: A Review of Early Findings and Future Applications |
| Q24299777 | Liver X receptor activation downregulates organic anion transporter 1 (OAT1) in the renal proximal tubule |
| Q36095017 | Longitudinal measures of perfluoroalkyl substances (PFAS) in serum of Gullah African Americans in South Carolina: 2003-2013. |
| Q44614900 | Metabolism and disposition of gemfibrozil in Wistar and multidrug resistance-associated protein 2-deficient TR- rats |
| Q43430462 | Modeling single and repeated dose pharmacokinetics of PFOA in mice |
| Q35842999 | Molecular and cellular physiology of renal organic cation and anion transport |
| Q46316942 | Oral (Gavage) Combined Developmental and Perinatal/Postnatal Reproduction Toxicity Study of Ammonium Salt of Perfluorinated Hexanoic Acid in Mice |
| Q51734932 | Organic Anion Transporting Polypeptides Contribute to the Disposition of Perfluoroalkyl Acids in Humans and Rats. |
| Q35631058 | PPARalpha agonist-induced rodent tumors: modes of action and human relevance |
| Q89845047 | Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study |
| Q53225736 | Perfluoroalkyl acids and related chemistries--toxicokinetics and modes of action. |
| Q34630884 | Perfluoroalkyl acids: a review of monitoring and toxicological findings |
| Q57482809 | Perfluoroalkyl substances in diamondback terrapins (Malaclemys terrapin) in coastal South Carolina |
| Q41582524 | Perfluorononanoic acid in combination with 14 chemicals exerts low-dose mixture effects in rats |
| Q47145555 | Perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts Scientific Opinion of the Panel on Contaminants in the Food chain |
| Q35996130 | Perfluorooctanoic acid effects on ovaries mediate its inhibition of peripubertal mammary gland development in Balb/c and C57Bl/6 mice |
| Q57858467 | Phase-out-compliant fluorosurfactants: unique methimazolium derivatives including room temperature ionic liquids |
| Q50668970 | Repeated dose and reproductive/developmental toxicity of perfluorododecanoic acid in rats. |
| Q98167045 | Risk Assessment of Per- and Polyfluoroalkyl Substances (PFASs) Mixtures: A Relative Potency Factor Approach |
| Q39997446 | Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid. |
| Q33592983 | Roles of rat renal organic anion transporters in transporting perfluorinated carboxylates with different chain lengths |
| Q89754498 | Serum Levels of Perfluoroalkyl Substances (PFAS) in Adolescents and Young Adults Exposed to Contaminated Drinking Water in the Veneto Region, Italy: A Cross-Sectional Study Based on a Health Surveillance Program |
| Q40452643 | Sex Differences in Human and Animal Toxicology. |
| Q40256300 | Sex difference in the prevalence of metabolic syndrome and cardiovascular-related risk factors in urban adults from 33 communities of China: The CHPSNE study |
| Q38024404 | Sex-related differences in renal toxicodynamics in rodents. |
| Q44351415 | Strong associations of short-chain perfluoroalkyl acids with serum albumin and investigation of binding mechanisms |
| Q37286520 | Testosterone-Mediated Endocrine Function and TH1/TH2 Cytokine Balance after Prenatal Exposure to Perfluorooctane Sulfonate: By Sex Status. |
| Q34343282 | The toxicology of perfluorooctanoate |
| Q37314370 | Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis |
| Q92109687 | Toxicokinetics of perfluorobutane sulfonate (PFBS), perfluorohexane-1-sulphonic acid (PFHxS), and perfluorooctane sulfonic acid (PFOS) in male and female Hsd:Sprague Dawley SD rats after intravenous and gavage administration |
| Q42915460 | Uptake and elimination of perfluorinated phosphonic acids in the rat. |
Search more.